Literature DB >> 11382198

Quantitative myotonia assessment: an experimental protocol.

V Sansone1, K Marinou, J Salvucci, G Meola.   

Abstract

Severe clinical myotonia can be physically disabling and socially impairing but as yet there is no standardized treatment regimen. The aim of our study is to present a protocol to measure myotonia using quantitative muscle assessment measures. The proposed protocol addresses two main issues. Muscle strength is assessed in 8 muscles on the right and on the left using a myometer (QMA, quantitative muscle assessment) and by testing strength manually using the 5-point MRC scale (5 = normal) in 15 muscles on the right and on the left. Grip myotonia is assessed by: (a) measuring 1/2 and 3/4 relaxation times (RT) after maximum voluntary contraction (MVC) using QMA apparatus; (b) functional tests (time to open a fist 10 times, time to open and squeeze the eyes 10 times, time to climb 10 steps starting from a seated position, time to protrude the tongue 10 times, time to step onto a chair 10 times; (c) subjective measures of the severity of myotonia using an arbitrary 4-point scale (0 = absent, 4 = severe); and (d) electromyography (EMG) relaxation times after MVC. Although QMA seems to be a reliable tool to measure myotonia, there are still a number of unsolved issues. Further studies are needed to ensure the ability of QMA to quantify myotonia and to guarantee the reliability of the results for clinical research purposes.

Entities:  

Mesh:

Year:  2000        PMID: 11382198     DOI: 10.1007/s100720070012

Source DB:  PubMed          Journal:  Neurol Sci        ISSN: 1590-1874            Impact factor:   3.307


  8 in total

1.  Case 12: my doctor says that I have ALS!

Authors:  Robin K Wilson; Vinay Chaudhry
Journal:  MedGenMed       Date:  2006-03-22

2.  A quantitative measure of handgrip myotonia in non-dystrophic myotonia.

Authors:  Jeffrey M Statland; Brian N Bundy; Yunxia Wang; Jaya R Trivedi; Dipa Raja Rayan; Laura Herbelin; Merideth Donlan; Rhonda McLin; Katy J Eichinger; Karen Findlater; Liz Dewar; Shree Pandya; William B Martens; Shannon L Venance; Emma Matthews; Anthony A Amato; Michael G Hanna; Robert C Griggs; Richard J Barohn
Journal:  Muscle Nerve       Date:  2012-10       Impact factor: 3.217

3.  Oral motor movements and swallowing in patients with myotonic dystrophy type 1.

Authors:  Beatriz Ercolin; Fernanda Chiarion Sassi; Laura Davison Mangilli; Lucia Iracema Zanotto Mendonça; Suelly Cecilia Olivan Limongi; Claudia Regina Furquim de Andrade
Journal:  Dysphagia       Date:  2013-03-05       Impact factor: 3.438

Review 4.  Drug treatment for myotonia.

Authors:  J Trip; G Drost; B G M van Engelen; C G Faber
Journal:  Cochrane Database Syst Rev       Date:  2006-01-25

5.  In vivo myograph measurement of muscle contraction at optimal length.

Authors:  Niels Rahe-Meyer; Christian Weilbach; Matthias Karst; Matthias Pawlak; Aminul Ahmed; Siegfried Piepenbrock; Michael Winterhalter
Journal:  Biomed Eng Online       Date:  2007-01-02       Impact factor: 2.819

6.  Relationships between grip strength, myotonia, and CTG expansion in myotonic dystrophy type 1.

Authors:  Jean-Yves Hogrel; Gwenn Ollivier; Isabelle Ledoux; Luc J Hébert; Bruno Eymard; Jack Puymirat; Guillaume Bassez
Journal:  Ann Clin Transl Neurol       Date:  2017-11-07       Impact factor: 4.511

7.  Toward a more personalized motor function rehabilitation in Myotonic dystrophy type 1: The role of neuroplasticity.

Authors:  Simona Portaro; Antonino Naro; Antonino Chillura; Luana Billeri; Alessia Bramanti; Placido Bramanti; Carmelo Rodolico; Rocco Salvatore Calabrò
Journal:  PLoS One       Date:  2017-05-25       Impact factor: 3.240

8.  Assessment of precision and reproducibility of a new myograph.

Authors:  Niels Rahe-Meyer; Michael Winterhalter; Aminul I Ahmed; Christian Weilbach; Matthias Gross; Siegfried Piepenbrock; Matthias Pawlak
Journal:  Biomed Eng Online       Date:  2007-12-20       Impact factor: 2.819

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.